Penn team spotlights a pilot ovarian cancer trial and survival rates for a personalized cancer vaccine
A group of investigators at Penn are holding out hope that a new type of personalized tumor vaccine may break the crippling run of failures …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
